Task: Answer the multiple-choice question.
Question: Which compound exhibits a -76.966% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a) O=C1CC(C(=O)Nc2ccc(C(=O)O)cc2)C(c2ccccc2)O1
b) CC1CCN(CCCn2c(SCC(=O)NC3CCCC3)nc3ccccc3c2=O)CC1
c) CCCNC(=O)c1onc(CSc2ccccc2)c1C(=O)NCCC
Answer: b. CC1CCN(CCCn2c(SCC(=O)NC3CCCC3)nc3ccccc3c2=O)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1CCN(CCCn2c(SCC(=O)NC3CCCC3)nc3ccccc3c2=O)CC1
CC1CCN(CCCn2c(SCC(=O)NC3CCCC3)nc3ccccc3c2=O)CC1
N-cyclopentyl-2-[3-[3-(4-methylpiperidin-1-yl)propyl]-4-oxoquinazolin-2-yl]sulfanylacetamide